These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 542606)

  • 41. [Present status of fibrates in the treatment of hyperlipoproteinemias].
    Soska V
    Vnitr Lek; 1999 Jul; 45(7):438-40. PubMed ID: 11045165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
    Honorato Pérez J; Azanza Perea JR
    Rev Med Univ Navarra; 1982 Mar; 26(1):51-4. PubMed ID: 7111953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society].
    Ceska R; Cífková R; Poledne R; Rosolová H; Soska V; Simon J; Sobra J; Vaverková H; Widimský J; Widimský J; Zadák Z
    Cas Lek Cesk; 1997 Apr; 136(8):257-61. PubMed ID: 9264871
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drug treatment of hyperlipoproteinemia].
    Chanu B
    Soins; 1987 Jul; (502):21-6. PubMed ID: 3672153
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in lipoprotein metabolism. III. Treatment].
    Sienra Pérez JC; Posadas Romero C
    Arch Inst Cardiol Mex; 1991; 61(3):267-77. PubMed ID: 1929676
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diet therapy of familial hyperlipoproteinemias in children].
    Singer L
    Cesk Pediatr; 1985 Sep; 40(9):533-9. PubMed ID: 4075425
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacotherapy of hyperlipoproteinemias: indications, mechanisms of action, effectiveness and side effects].
    Schernthaner G; Woschnagg H
    Wien Med Wochenschr; 1990 Feb; 140(3):64-75. PubMed ID: 2180212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bulk materials in hyperlipoproteinemias].
    Huth K
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):477-8. PubMed ID: 6246416
    [No Abstract]   [Full Text] [Related]  

  • 49. The hyperlipoproteinemias.
    Whayne TF
    J Fam Pract; 1980 Nov; 11(5):789-99. PubMed ID: 7430980
    [No Abstract]   [Full Text] [Related]  

  • 50. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of hyperlipoproteinemia with lipanthyl].
    Kalinová M; Zadák Z; Sobotka L
    Cas Lek Cesk; 1983 Feb; 122(7):205-8. PubMed ID: 6831503
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hyperlipoproteinemias. Epidemiology, etiology, physiopathology, diagnosis, treatment].
    Chadarevian R; Cohen-Presberg P; Bruckert E; Turpin G
    Rev Prat; 1998 Jun; 48(12):1353-9. PubMed ID: 9781197
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nutrition in hyperlipoproteinemias from the preventive and therapeutic viewpoint].
    Hanefeld M
    Z Arztl Fortbild (Jena); 1984; 78(18):757-61. PubMed ID: 6095544
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dietary treatment of hyper- and dyslipoproteinemias].
    Biermann J; Herrmann W
    Z Arztl Fortbild (Jena); 1990; 84(13):645-7. PubMed ID: 2238720
    [No Abstract]   [Full Text] [Related]  

  • 55. Apolipoprotein A1 and B.
    Sniderman AD; Marcovina SM
    Clin Lab Med; 2006 Dec; 26(4):733-50. PubMed ID: 17110237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dietary treatment of hyperlipoproteinemia (author's transl)].
    Schlierf G; Oster P
    Ther Umsch; 1980 Nov; 37(11):985-9. PubMed ID: 7455964
    [No Abstract]   [Full Text] [Related]  

  • 57. [Dietary treatment of hyperlipoproteinemia].
    Chanu B
    Soins; 1987 Jul; (502):15-20. PubMed ID: 3672152
    [No Abstract]   [Full Text] [Related]  

  • 58. [Management of hyperlipoproteinemias].
    Battocchia A; Girotto S; Residori P; Negri L; Filippini M; Negri A; Biti L; Daniotti S
    Recenti Prog Med; 1983 Apr; 74(4):492-512. PubMed ID: 6878862
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hyperlipoproteinemia. Epidemiology, physiopathology, diagnosis, principles of dietary and drug treatment].
    Brun JM; Pacaud A
    Rev Prat; 1992 Jun; 42(11):1412-8. PubMed ID: 1529258
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
    Reiner Z; Salzer B; Kes P
    Acta Med Iugosl; 1988; 42(5):353-62. PubMed ID: 3245481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.